Latest News about BGNE
Recent news which mentions BGNE
From Benzinga
New Energy Lands as Hottest Category Among Chinese Concept Stocks in 2021 – Bamboo Works Special Report
January 26, 2022
From Benzinga
Immix Biopharma's IMX-110 / Anti-PD-1 Combo Therapy Shows Extended Median Survival In Animal Studies
January 25, 2022
From Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
From Benzinga
Why Leap Therapeutics Stock Is Surging Today
January 19, 2022
From Motley Fool
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
From Benzinga
Leap Therapeutics Says DKN-01 Combo Regime Show Compelling Efficacy In Gastric Cancer Patients
January 19, 2022
From Benzinga
2 Risky Growth Stocks That Could Make You Filthy Rich
January 16, 2022
From Motley Fool
From InvestorPlace
From Benzinga
46 Biggest Movers From Yesterday
December 16, 2021
From Benzinga
Why Shares of BeiGene and Zai Lab Are Tanking Today
December 15, 2021
From Motley Fool
36 Stocks Moving In Wednesday's Mid-Day Session
December 15, 2021
From Benzinga
From InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
December 15, 2021
From Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
December 10, 2021
From Benzinga
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
December 09, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
BeiGene - EUSA Pharma's Siltuximab Approved In China For Multicentric Castleman Disease
December 03, 2021
Tickers
BGNE
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
November 24, 2021
From Benzinga
BeiGene's Brukinsa Approved In Europe For Rare Type Of Blood Cancer
November 24, 2021
Tickers
BGNE
From Benzinga
2 Growth Stocks That Could Deliver 1,000% Returns
October 31, 2021
From Motley Fool
2 Penny Stocks That Could Soar Soon
October 14, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
3 Biotech Stocks That Surged in September
October 05, 2021
From Motley Fool
This Potential Indication Could Be a Winner for Novartis
September 29, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.